Leishmanial selenoproteins and the host immune system: towards new therapeutic strategies?

Trans R Soc Trop Med Hyg. 2020 Jul 1;114(7):541-544. doi: 10.1093/trstmh/traa013.

Abstract

Optimum levels of selenoproteins are essential for starting and managing the host immune responses against pathogens. According to the expression of selenoproteins in Leishmania parasites, and since high levels of selenoproteins lead to adverse effects on immune cells and their functions, Leishmania parasites might then express selenoproteins such as selenomethionine in their structure and/or secretions able to challenge the host immune system. Finally, this adaptation may lead to evasion of the parasite from the host immune system. The expression of selenoproteins in Leishmania parasites might then induce the development of infection. We therefore suggest these molecules as new therapeutic candidates for the treatment of leishmaniasis.

Keywords: Leishmania; immune system; selenomethionine; selenoprotein; therapeutic candidate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immune System
  • Leishmania*
  • Leishmaniasis* / drug therapy
  • Selenoproteins

Substances

  • Selenoproteins